Model recapitulates key physiological features of native endosteal niches, and could aid in the study of blood formation in both healthy and diseased conditions.

Starting in 2026, NIBRT training will be piloted at Heartland BioWorks’ Indianapolis headquarters with hands-on training beginning in 2027.

Johnson & Johnson has agreed to acquire Halda Therapeutics for $3.05 billion cash, in a deal designed to expand the buyer’s cancer pipeline with Halda’s precision oncology candidates, led by a ...

A molecular switch in breast cancer cells reprograms the genetic production line towards tumor growth and stress resistance.